Literature DB >> 27928336

Saturday Night Retinopathy with Ophthalmoplegia: A Case Series.

Mehrdad Malihi1, Roger E Turbin1, Larry P Frohman1.   

Abstract

The purpose of this study was to present three cases of Saturday night retinopathy. The study design was observational case series. We described three cases who presented to our centre with acute visual loss following intravenous drug abuse and stupor leading to continuous pressure on the orbit while asleep. All cases presented with acute vision loss and had funduscopic evidence of ophthalmic or central retinal artery occlusion. Two of the cases presented with ophthalmoplegia and proptosis. One of the cases had significantly increased intraocular pressure with corneal oedema. All cases had fixed and non-reactive pupils with significant relative afferent pupillary defect. One case also had accompanying peroneal nerve damage. All three cases had poor visual outcomes. Saturday night retinopathy is a blinding condition with either central retinal or ophthalmic artery occlusion, which may present with transient orbital congestion and ophthalmoplegia. It may be accompanied by other nerve damage from compression in other parts of the body and is caused by prolonged positional pressure on the orbit.

Entities:  

Keywords:  Ophthalmoplegia; retinal artery occlusion; saturday night retinopathy

Year:  2015        PMID: 27928336      PMCID: PMC5123184          DOI: 10.3109/01658107.2014.997889

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  14 in total

1.  Occlusion of the central retinal artery following anesthesia.

Authors:  I GIVNER; N JAFFE
Journal:  Arch Ophthal       Date:  1950-02

2.  Efficacy and safety of intra-arterial thrombolysis in central retinal artery occlusion.

Authors:  Seong Joon Ahn; Jae Min Kim; Jeong-Ho Hong; Se Joon Woo; Jeeyun Ahn; Kyu Hyung Park; Moon-Ku Han; Cheolkyu Jung
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-21       Impact factor: 4.799

Review 3.  A review of central retinal artery occlusion: clinical presentation and management.

Authors:  D D Varma; S Cugati; A W Lee; C S Chen
Journal:  Eye (Lond)       Date:  2013-03-08       Impact factor: 3.775

4.  Saturday night retinopathy.

Authors:  A V Jayam; W K Hass; R E Carr; A J Kumar
Journal:  J Neurol Sci       Date:  1974-08       Impact factor: 3.181

5.  Central retinal artery occlusion and retinal tolerance time.

Authors:  S S Hayreh; H E Kolder; T A Weingeist
Journal:  Ophthalmology       Date:  1980-01       Impact factor: 12.079

6.  Visual field defect after posterior spine fusion.

Authors:  Danielle A Katz; Lawrence I Karlin
Journal:  Spine (Phila Pa 1976)       Date:  2005-02-01       Impact factor: 3.468

7.  Blindness and rectus muscle damage following spinal surgery.

Authors:  Nishant Kumar; Sharmila Jivan; Nicola Topping; Andrew J Morrell
Journal:  Am J Ophthalmol       Date:  2004-11       Impact factor: 5.258

Review 8.  Central retinal artery occlusion after scoliosis surgery with a horseshoe headrest. Case report and literature review.

Authors:  W Grossman; W T Ward
Journal:  Spine (Phila Pa 1976)       Date:  1993-07       Impact factor: 3.468

9.  Release hallucinations and visual loss as first manifestations of postoperative unilateral blindness.

Authors:  J A Montero; J M Ruiz-Moreno; A Galindo; M Fernandez-Muñoz
Journal:  Eur J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 2.597

10.  Treatment options for central retinal artery occlusion.

Authors:  Sudha Cugati; Daniel D Varma; Celia S Chen; Andrew W Lee
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

View more
  2 in total

1.  Saturday night retinopathy and anterograde amnesia due to fentanyl overdose.

Authors:  Joshua Budhu; Illya Tolokh; Marc Bouffard; Shirley H Wray; Marcelo Matiello
Journal:  Neurol Clin Pract       Date:  2019-04

Review 2.  Illicit drugs: Effects on eye.

Authors:  Deepika Dhingra; Savleen Kaur; Jagat Ram
Journal:  Indian J Med Res       Date:  2019-09       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.